Aditxt earnings were -$36.9M for the trailing 12 months ending Jun 30, 2025, with -86.9% growth year over year. The latest ADTX earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$7.3M, up 27.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ADTX reported annual earnings of -$46.3M, with 40.1% growth.
ADTX past earnings growth
How has ADTX's earnings growth performed historically?
Aditxt (NASDAQ: ADTX) reported Q2 2025 earnings per share (EPS) of -$3.45, up 99.67% year over year. Total ADTX earnings for the quarter were -$7.26 million. In the same quarter last year, Aditxt's earnings per share (EPS) was -$1,047.17.
As of the last Aditxt earnings report, Aditxt is currently losing money. Aditxt's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$31.04 million, a 28.33% decrease year over year.
What was ADTX's earnings growth in the past year?
As of Aditxt's earnings date in Q3 2025, Aditxt's earnings has grown -86.9% year over year. This is 117.01 percentage points lower than the US Biotechnology industry earnings growth rate of 30.11%. ADTX earnings in the past year totalled -$36.95 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.